tiprankstipranks
Cytokinetics opens enrollment for COMET-HF Phase 3 trial
PremiumThe FlyCytokinetics opens enrollment for COMET-HF Phase 3 trial
2M ago
Cytokinetics announces FDA acceptance of NDA for aficamten
Premium
The Fly
Cytokinetics announces FDA acceptance of NDA for aficamten
2M ago
Cytokinetics price target raised to $103 from $99 at Mizuho
Premium
The Fly
Cytokinetics price target raised to $103 from $99 at Mizuho
2M ago
Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
PremiumThe FlyMolson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
2M ago
Cytokinetics initiated with an Outperform at RBC Capital
Premium
The Fly
Cytokinetics initiated with an Outperform at RBC Capital
2M ago
Cytokinetics’ Q3 2024: Progress and Financial Insights
Premium
Company Announcements
Cytokinetics’ Q3 2024: Progress and Financial Insights
2M ago
Cytokinetics to provide an update on cardiac myosin modulation programs
PremiumThe FlyCytokinetics to provide an update on cardiac myosin modulation programs
3M ago
Cytokinetics price target raised to $120 from $90 at H.C. Wainwright
Premium
The Fly
Cytokinetics price target raised to $120 from $90 at H.C. Wainwright
3M ago
Cytokinetics presents additional data from SEQUOIA-HCM trial
Premium
The Fly
Cytokinetics presents additional data from SEQUOIA-HCM trial
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100